Stocks and Investing
by (remove) : Neena Bitritto-Garg
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Neena Bitritto-Garg
RSSJSONXMLCSV
Mon, March 11, 2024
Thu, December 14, 2023
Tue, December 12, 2023
Fri, July 14, 2023
Fri, June 23, 2023
Tue, May 9, 2023
Tue, April 4, 2023
Tue, March 14, 2023
Wed, March 1, 2023
Tue, February 28, 2023
Tue, January 31, 2023
Mon, January 9, 2023
Thu, November 10, 2022
Mon, October 3, 2022
Thu, September 8, 2022
Thu, September 1, 2022
Mon, August 8, 2022
Fri, August 5, 2022
Mon, July 11, 2022
Wed, July 6, 2022
Wed, June 22, 2022
Tue, June 14, 2022
Wed, May 25, 2022
Tue, May 17, 2022
Fri, February 25, 2022
Wed, January 5, 2022

Neena Bitritto-Garg Maintained (AMLX) at Strong Buy with Decreased Target to $8 on, Mar 11th, 2024


Published on 2024-10-28 09:36:17 - WOPRAI, Neena Bitritto-Garg
  Print publication without navigation


Neena Bitritto-Garg of Deutsche Bank, Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy with Decreased Target from $36 to $8 on, Mar 11th, 2024.

Neena has made no other calls on AMLX in the last 4 months.



There are 2 other peers that have a rating on AMLX. Out of the 2 peers that are also analyzing AMLX, 1 agrees with Neena's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Umer Raffat of "Evercore ISI Group" Downgraded from Buy to Hold on, Friday, March 8th, 2024


This is the rating of the analyst that currently disagrees with Neena


  • Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy with Increased Target to $32 on, Friday, March 8th, 2024
Contributing Sources